Most patients with advanced malignancy will die of their disease. Care of the dying is therefore a fundamental skill for the oncologist. Although protocols exist in other countries, there is no established protocol in the United States. We present a protocol for management of the dying that is clinically useful and review the existing evidence-base.
Lynn J., Teno JM, Phillips RS, et al. Perceptions by family members of the dying experience of older and seriously ill patients. Ann Intern Med. 1997;126(2):97-105.
2.
Grond S., Zech D., Schug S., Lynch J., Lehmann KAValidation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage . 1991;6(7): 411-422.
3.
Hwang SS, Chang VT, Faircloth DL, Cogswell J., Kasimis B.Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical center. J Pain Symptom Manage. 2003;25(3):225-235.
4.
Higginson IJ , Sen-Gupta GJA.Place of care in advanced cancer. A qualitative systematic literature review of patient preferences . J Palliat Med. 2000;3(3):287-300.
5.
Teno JM, Clarridge BR, Casey V., et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291(1):88-93.
6.
Enck REThe last few days. Am J Hosp Palliat Care. 1992;9(4): 11-13.
7.
Lichter I., Hunt E.The last 48 hours of life. J Palliat Care. 1990; 6(4):7-15.
8.
Nelson KA, Walsh D., Behrens C., Zhukovsky DS, Lipnickey V., Brady D.The dying cancer patient. Semin Oncol. 2000 ;27(1):84-89.
9.
Ellershaw JE, Wilkinson S.Care for the Dying: A Pathway to Excellence. Oxford : Oxford University Press; 2003 .
10.
O’Leary N.Diagnosis of death and dying. In: Walsh D, ed. Palliative Medicine. Philadelphia, PA: Saunders Elsevier; 2009.
11.
Dunn GP, Milch RAIs this a bad day or one of the last days? How to recognize and respond to approaching demise. J Am Coll Surg. 2002 ;195(6):879-887.
12.
Christakis NA, Lamont EBExtent and determinants of error in doctors’ prognoses ion terminally ill patients: prospective cohort study. BMJ. 2000;320(7322):469-473.
13.
Ellershaw J. , Ward C.Care of the dying patient: the last hours of days of life. BMJ. 2003;326(7379):30-34.
14.
Schneiderman LJ, Jecker NS, Jonsen ARMedical futility: its meaning and ethical implications. Ann Intern Med. 1990; 112(12):949-954.
15.
Walsh D., Rivera N., Davis MP, Lagman R., LeGrand S.Strategies for pain management: Cleveland clinic guidelines for opioid dosing for cancer pain. Supportive Cancer Ther. 2004 ;1(3):157-164.
16.
De Graeff A. , Dean MBPalliative sedation therapy in the last weeks of life. J Palliat Med. 2007 ;10(1):67-84.
17.
Sykes N., Thorns A.The use of opioids and sedatives at the end of life. Lancet Oncol. 2003;4(5):312-318.
18.
Jennings AL , Davies AN, Higgens JPT, Broadley KE, Anzures-Cabrera J.Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev. 2009:4.
19.
Bennett M., Lucas V., Brennan M., Hughes A., O’Donnell V., Wee B.Association for Palliative Medicine’s Science Committee. Using anti-muscarinic drugs in the management of death rattle: evidence-based guidelines for palliative care. Palliat Med. 2002;16(5):369-374.
20.
Wildiers H. , Dhaenekint C., Demeulenaere P., et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage.2009;38(1):124-133.
21.
Back IN, Jenkins K., Blower A., Beckhelling J.A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med. 2001 ;15(4):329-336.
22.
Breitbart W. , Gibson C., Tremblay A.The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics . 2002;43(3):183-194.
23.
Kehl K.Treatment of terminal restlessness: a review of the evidence. J Pain Palliat Care Pharmacother. 2004;18(1):5-30.
24.
McIver B., Walsh D., Nelson K.The use of chlorpromazine for symptom control in dying cancer patient. J Pain Symptom Manage. 1994;9(5):341-345.
25.
Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JCTrends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2994;22(2):315-321.
26.
Kao S., Shafiq J., Vardy J., Adams D.Use of chemotherapy at end of life in oncology patients. Ann Oncol.2009;20(9):1555-1569.
27.
Fainsinger R., Miller MJ, Bruera E.Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7(1):5-11.
28.
Reuben DB, Mor V.Dyspnea in terminally ill cancer patients. Chest. 1986;89(2):234-236.
29.
Ben-Aharon I., Gafter-Gvili A., Paul M., Leibovici L., Stemmer SMInterventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol. 2008;26(14):2396-2404.
30.
Viola R., Kitely C., Lloyd ND, et al. The management of dyspnea in cancer patients: a systematic review . Support Care Cancer. 2008;16(4):329-337.
31.
Wildiers H. , Menten J.Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage. 2002;23(4):310-317.
32.
Wee B., Coleman PG, Hillier R., Holgate SHThe sound of death rattle I: are relatives distressed by hearing this sound ? Palliat Med. 2006;20(3):171-175.
33.
Wee BL, Coleman PG, Hillier R., Holgate SHThe sound of death rattle II: how do relatives interpret the sound ? Palliat Med. 2006; 20(3):177-181.
34.
McCann RM , Hall WJ, Groth-Juncker A.Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA. 1994;272(16):1263-1266.
35.
Van der Riet P., Brooks D., Ashby M.Nutrition and hydration at the end of life: pilot study of a palliative care experience. J Law Med. 2006;14(2):182-198.
36.
Fainsinger RD, Bruera E.When to treat dehydration in a terminally ill patient. Support Care Cancer. 1997;5(3):209-211.
37.
Viola RA, Wells GA, Petersen J.The effects of fluid status and fluid therapy on the dying: a systematic review . J Palliat Care. 1997;13(4):41-52.
38.
Lennard-Jones JEGiving or withholding fluids and nutrients: ethical and legal aspects. J R Coll Physicians Lond. 1999;33(1):39-45.
39.
Back INTerminal restlessness in patients with advanced malignant disease . Palliat Med. 1992;6(4):293-298.
40.
White C., McCann MA, Jackson N.First do no harm terminal restlessness or drug-induced delirium. J Palliat Med. 2007;10(2): 345-351.
41.
Cherny NI, Portenoy RKSedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care. 1994;10(2):31-38.
42.
Maltoni M., Pittureri C., Scarpi E., et al. Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol.2009;20(7):1163-1169.
43.
Cowen JD, Walsh D.Terminal sedation in palliative medicine- definition and review of the literature . Support Care Cancer. 2001 ;9(6):403-407.
